3 Meter Backwards Walk Test and Multiple Sclerosis
The Validity and Reliability of 3 Meter Backwards Walk Test in Multiple Sclerosis Patients
1 other identifier
observational
40
1 country
1
Brief Summary
Multiple Sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system that causes different levels of disability with motor and sensory loss. Although the signs and symptoms of the disease vary according to the location of the lesion; loss of strength, spasticity, sensory disturbances, fatigue, ataxia, autonomic dysfunction and decreased visual acuity are frequently seen. One of the most important causes of loss of function is balance problems. Balance problems, on the other hand, result in falls that cause severe injuries. One of the most important goals in the rehabilitation of individuals with MS is to increase their performance by minimizing the risk of falling in their daily lives. For medical professionals, many medical history questionnaires, self-assessment measures and performance-based tests have been developed to determine the risk of falls. Performance-based functional assessments consist of a timed walk and walk test, functional skill, balance and fall risk, 5 times sit-and-go test and Berg Balance Test, 4 square step test and gait speed measurement tests. These tests include the ability to walk forward and revolve around ones priorities. However, walking is a more difficult activity as it involves neuromuscular control and is dependent on proprioception and protective reflexes. In daily life activities, there is a need to walk backwards to perform tasks such as leaning against a chair and opening the door. This movement can be quite challenging especially for elderly people with neurological deficits. It has been noted that the mechanical measurements of the back support, in particular the speed, the step length, and the double support surface are significantly reduced in older adults. In a study conducted in geriatric individuals, it was shown that walking backward was more sensitive to detect age-related changes in mobility and balance than walking forward. The aim of this study is to determine the validity and reliability of the 3-meter backwards walk test for evaluating performance-based fall risk in individuals with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2019
CompletedFirst Posted
Study publicly available on registry
July 1, 2019
CompletedStudy Start
First participant enrolled
July 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedApril 14, 2021
April 1, 2021
10 months
June 27, 2019
April 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
3 m backwards walk test
465/5000 A distance of 3 m is measured and marked with black tape. Individuals are asked to follow the heel and black band. With the 'start' command they are asked to walk backwards quickly. When the distance of 3 m is completed, a stop is instructed. Individuals are not allowed to run during the test. They are allowed to look back if they wish. The assessor walks behind individuals throughout the test. The test is repeated 3 times, the averages are recorded
First and second days
Secondary Outcomes (5)
Timed up and go test
First day
12 Items MS Walking Scale
First day
2 min walk test
First day
25 foot walk test
First day
4 square step test
First day
Study Arms (1)
Multiple sclerosis patient
First day, first evaluator will perform all tests, and second day, second evaluator will perform 3 m backwards walk test.
Interventions
3-m backwards walk test, timed up and go test, 12-item MS Walking Scale, 2-min walk test, timed 25-foot walk test, 4-square step test.
Eligibility Criteria
Multiple Sclerosis patient
You may qualify if:
- EDSS score is 4 or less,
You may not qualify if:
- Pregnancy or in the first 3 months after birth,
- Corticosteroid treatment in the last month
- Using medication that will affect walking in the last 1 month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sanko Universitylead
Study Sites (1)
SANKO University
Gaziantep, Şehitkamil, 27090, Turkey (Türkiye)
Related Publications (1)
Carter V, Jain T, James J, Cornwall M, Aldrich A, de Heer HD. The 3-m Backwards Walk and Retrospective Falls: Diagnostic Accuracy of a Novel Clinical Measure. J Geriatr Phys Ther. 2019 Oct/Dec;42(4):249-255. doi: 10.1519/JPT.0000000000000149.
PMID: 29095771BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zekiye İpek Katırcı Kırmacı, Ph.D(c)
Sanko University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
June 27, 2019
First Posted
July 1, 2019
Study Start
July 1, 2019
Primary Completion
April 15, 2020
Study Completion
June 30, 2020
Last Updated
April 14, 2021
Record last verified: 2021-04